Global AI in Medical Imaging Market to Anticipate Impressive Growth Trajectory at a CAGR of ~29% by 2032 | DelveInsight
The global AI in medical imaging market is expanding due to the growing incidence of chronic diseases such as cancer, cardiovascular, and neurological disorders, which heighten the need for precise and efficient diagnostic tools. Supportive government initiatives and funding are driving the digitization of healthcare and the integration of AI, while major industry players are focusing on innovation and strategic partnerships to enhance imaging technologies. Moreover, rapid progress in deep learning, machine learning, and computer vision is significantly enhancing diagnostic accuracy, workflow efficiency, and predictive performance, thereby driving global market growth.
New York, USA, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Global AI in Medical Imaging Market to Anticipate Impressive Growth Trajectory at a CAGR of ~29% by 2032 | DelveInsight
The global AI in medical imaging market is expanding due to the growing incidence of chronic diseases such as cancer, cardiovascular, and neurological disorders, which heighten the need for precise and efficient diagnostic tools. Supportive government initiatives and funding are driving the digitization of healthcare and the integration of AI, while major industry players are focusing on innovation and strategic partnerships to enhance imaging technologies. Moreover, rapid progress in deep learning, machine learning, and computer vision is significantly enhancing diagnostic accuracy, workflow efficiency, and predictive performance, thereby driving global market growth.
DelveInsight’s AI in Medical Imaging Market Insights report provides the current and forecast market analysis, individual leading AI in medical imaging companies’ market shares, challenges, AI in medical imaging market drivers, barriers, trends, and key AI in medical imaging companies in the market.
AI in Medical Imaging Market Summary
- The global AI in medical imaging market size is expected to increase from USD 1.6 billion in 2024 to ~USD 13 billion by 2032, reflecting strong and sustained growth.
- The global AI in medical imaging market is expected to grow at a CAGR of ~29% during the forecast period from 2025 to 2032.
- The leading companies working in the AI in medical imaging market include GE HealthCare, iRhythm Technologies, Royal Health Inc., Koninklijke Philips N.V., Abbott, Siemens Healthcare Private Limited, Canon Medical Systems, Fujifilm Holdings Corporation, Hologic, Inc., AGFA Healthcare, IBM Watson Health, Zebra Medical Vision, Aidoc, TEMPUS, Enlitic®, Inc., HeartFlow, Inc., Lunit Inc., RadNet, Inc., Qure.ai, VUNO, Inc., and others.
- Among all the regions, North America is anticipated to register the fastest growth in the AI in medical imaging market during the forecast period.
- In the technology segment of the artificial intelligence in medical imaging market, the deep machine learning category accounted for the largest market share in 2024.
To read more about the latest highlights related to AI in medical imaging market, get a snapshot of the key highlights entailed in the Global AI in Medical Imaging Market Forecast Report
Key Factors Contributing to the Rise in Growth of the AI in Medical Imaging Market
The Growing Prevalence of Chronic Diseases
The growing prevalence of chronic diseases, including cancer, cardiovascular, and neurological disorders, is fueling the need for advanced diagnostic technologies. These conditions often demand regular and precise imaging to track disease progression and inform treatment strategies. AI-driven medical imaging systems facilitate faster analysis, enhance the detection of subtle abnormalities, and provide predictive insights that are essential for effective disease management. Consequently, healthcare organizations are rapidly adopting AI-based imaging tools to enhance diagnostic accuracy, minimize errors, and improve patient outcomes, thereby accelerating market expansion.
Increasing Product Development Activities Among Key Market Players
Leading market players are heavily investing in R&D to develop sophisticated AI algorithms, integrate AI with imaging systems, and enhance software functionalities. Ongoing innovation is boosting the precision, speed, and scalability of medical imaging technologies, increasing their appeal to healthcare professionals. In addition, companies are pursuing collaborations, partnerships, and acquisitions to fast-track innovation and introduce advanced AI-driven imaging tools to the market. These strategic initiatives are intensifying competition, strengthening technological capabilities, and broadening the global market by delivering superior diagnostic solutions to hospitals and imaging centers.
Increase in Government Initiatives and Funding Support across the Globe
Government-backed programs and funding initiatives that promote healthcare digitization, AI research, and smart hospital infrastructure are driving the rapid adoption of AI in medical imaging. Through grants, subsidies, and supportive regulations, these efforts help reduce the financial strain on hospitals and technology developers, fostering greater investment in AI-powered diagnostic tools. Additionally, policies emphasizing early disease detection, precision medicine, and healthcare innovation create a favorable landscape for implementing AI technologies. Together, these measures not only boost market adoption but also stimulate research and development, paving the way for more advanced and efficient AI imaging solutions.
Get a sneak peek at the AI in medical imaging market dynamics @ AI in Medical Imaging Market Trends
Regional AI in Medical Imaging Market Insights
North America, spearheaded by the United States, held a commanding 42% share of the global Ai in medical imaging market in 2024. This leadership stems from the region’s robust healthcare infrastructure, early adoption of cutting-edge technologies, and the strong presence of top AI firms and imaging equipment manufacturers. Factors such as substantial government funding, favorable regulatory initiatives, like the U.S. FDA’s accelerated approval process for AI-based imaging tools, and high healthcare spending further strengthen its market position. Moreover, the growing burden of chronic diseases, including cancer and cardiovascular conditions, along with close collaboration among technology companies, research institutions, and healthcare providers, continues to drive North America’s dominance in AI-powered medical imaging innovation and adoption.
In Europe, the Artificial Intelligence in Medical Imaging market is progressing steadily, supported by advanced healthcare systems, increasing investment in digital health initiatives, and a focus on precision medicine. Leading nations such as Germany, the U.K., France, and Switzerland are at the forefront of implementing AI-driven imaging technologies to enhance early disease detection, streamline clinical workflows, and enable personalized care. The region’s growing incidence of chronic illnesses, ranging from cancer and cardiovascular diseases to neurological and respiratory disorders, is fueling demand for more accurate and efficient diagnostic solutions.
The Asia-Pacific region is witnessing rapid expansion in the Artificial Intelligence in Medical Imaging market, driven by surging healthcare investments, increasing prevalence of chronic diseases, and accelerated adoption of digital health. Countries, including China, Japan, South Korea, and India, are making substantial investments in AI-enabled diagnostic infrastructure, such as advanced imaging technologies and cloud-based AI systems, to enhance early disease detection and improve clinical outcomes. The escalating rates of cancer, cardiovascular ailments, diabetes, and neurological disorders are further boosting the need for high-precision, AI-assisted diagnostic tools across the region.
To know more about why North America is leading the market growth in the AI in medical imaging market, get a snapshot of the AI in Medical Imaging Market Share
Recent Developmental Activities in the AI in Medical Imaging Market
- In August 2025, RIVANNA®, developers of imaging-based medical technologies, was awarded an $800,000 grant from the Virginia Catalyst Program to advance the Accuro® 3S diagnostic ultrasound system in collaboration with the University of Virginia and Virginia Commonwealth University.
- In August 2025, Nerveblox, an AI software developed by SmartAlpha to assist physicians with ultrasound-guided regional anesthesia, received FDA 510(k) clearance, enabling its launch in the U.S. healthcare market.
- In April 2025, the FDA granted clearance for this AI-enabled cardiac imaging software, enabling even non-experts to perform diagnostic-quality echocardiograms with just minimal training.
- In February 2025, RapidAI Lumina 3D was approved by the FDA via a 510(k) clearance. This AI-powered tool enables near-instant, high-quality 3D reconstructions (including vessel segmentation and bone removal) from CTA scans, particularly useful in neuroradiology.
What is AI in Medical Imaging?
Artificial intelligence (AI) is revolutionizing medical imaging by enhancing the accuracy, speed, and efficiency of image interpretation. AI algorithms, particularly those based on deep learning, can automatically detect patterns and anomalies in radiological images such as X-rays, CT scans, MRIs, and ultrasounds with remarkable precision. This capability enables clinicians to identify diseases earlier and more reliably, ranging from tumors and fractures to cardiovascular and neurological disorders. By automating routine tasks and reducing human error, AI allows radiologists to focus more on complex cases and patient care decisions.
| AI in Medical Imaging Market Report Metrics | Details |
| Coverage | Global |
| Study Period | 2022–2032 |
| AI in Medical Imaging Market CAGR | ~29% |
| AI in Medical Imaging Market Size by 2032 | ~USD 13 Billion |
| Key AI in Medical Imaging Companies | GE HealthCare, iRhythm Technologies, Royal Health Inc., Koninklijke Philips N.V., Abbott, Siemens Healthcare Private Limited, Canon Medical Systems, Fujifilm Holdings Corporation, Hologic, Inc., AGFA Healthcare, IBM Watson Health, Zebra Medical Vision, Aidoc, TEMPUS, Enlitic®, Inc., HeartFlow, Inc., Lunit Inc., RadNet, Inc., Qure.ai, VUNO, Inc., and others |
AI in Medical Imaging Market Assessment
-
AI in Medical Imaging Market Segmentation
- AI in Medical Imaging Market Segmentation By Technology: Machine Learning, Deep Machine Learning, Natural Language Processing, and Computer Vision
- AI in Medical Imaging Market Segmentation By Modality: X-ray Imaging, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound Imaging, and Others
- AI in Medical Imaging Market Segmentation By Offering: Hardware, Software, and Services
- AI in Medical Imaging Market Segmentation By Application: Oncology, Neurology, Cardiology, Orthopedics, and Others
- AI in Medical Imaging Market Segmentation By End-Users: Hospitals and Clinics, Diagnostic Imaging Centers, and Others
- AI in Medical Imaging Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the AI in medical imaging market are set to emerge as the trendsetter explore @ AI in Medical Imaging Market Analysis
Table of Contents
| 1 | AI in Medical Imaging Market Report Introduction |
| 2 | AI in Medical Imaging Market Executive Summary |
| 3 | Competitive Landscape |
| 4 | Regulatory Analysis |
| 5 | AI in Medical Imaging Market Key Factors Analysis |
| 6 | AI in Medical Imaging Market Porter’s Five Forces Analysis |
| 7 | AI in Medical Imaging Market Layout |
| 8 | AI in Medical Imaging Market Company and Product Profiles |
| 9 | KOL Views |
| 10 | Project Approach |
| 11 | About DelveInsight |
| 12 | Disclaimer & Contact Us |
Interested in knowing the AI in medical imaging market share by 2032? Click to get a snapshot of the AI in Medical Imaging Market Size
Related Reports
AI in Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in diagnostics companies, including Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, among others.
AI in Cancer Diagnostics Market
AI in Cancer Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in cancer diagnostics companies, including iCAD, Inc., ibex-ai, Roche Diagnostics, Kheiron Medical Technologies Limited, MVision AI Inc., Siemens Healthineers AG, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., IBM Corporation, Azra AI, ConcertAI, PathAI, Median Technologies, Paige AI Inc., Therapixel, Flatiron, Freenome Holdings Inc., Onc.AI, Sonrai Analytics, among others.
Artificial Intelligence In Clinical Trials Market
Artificial Intelligence In Clinical Trials Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in clinical trials companies, including TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, among others.
Artificial Intelligence In Drug Discovery Market
Artificial Intelligence in Drug Discovery Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in drug discovery companies, including IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, among others.
Artificial Intelligence in Precision Medicine Market
Artificial Intelligence in Precision Medicine Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in precision medicine companies, including TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., among others.
DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us Shruti Thakur info@delveinsight.com +14699457679
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
